Xi Wen Zhao

Xi Wen Zhao has a diverse work experience in the field of biomedical research and pharmaceuticals. They started their career as a QC Technician at Haikou QiLi Pharma Co., LTD in 2004, where they collected samples, performed microbiological testing, and generated reports. They then worked as an Internship at NKI-AVL in 2006 and as an Internship student at Leiden University Medical Center from 2006 to 2007. Xi Wen Zhao then pursued a PhD at Sanquin from 2008 to 2014, where they studied CD47-SIRPa interactions as a potential therapeutic target for cancer treatment. During this time, they also worked with patients and donors for research purposes. After completing their PhD, they joined the Neurosurgery Department at Cancer Center Amsterdam as a Postdoctoral Fellow from 2014 to 2015 and later became a Junior PI in 2016. They are currently working as a Senior Scientist at Harbour Biomed, starting from March 2017.

Xi Wen Zhao earned a Bachelor of Science degree from South China University of Tropical Agriculture between 2001 and 2005. Following this, Xi Wen Zhao attended the University of Amsterdam from 2005 to 2008, where they obtained a Master of Science degree in Molecular Biology. Xi Wen Zhao also holds a certification in Article 9 of the Experiments on Animals Act (Wet op de dierproeven (Wod)).